[
  {
    "ts": "2025-12-20T00:11:00+00:00",
    "headline": "Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson",
    "summary": "ST. PAUL, Minn., December 20, 2025--A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding that the company’s talc products exposed her to asbestos and contributed to her developing peritoneal mesothelioma, a cancer of the peritoneal lining in the stomach.",
    "url": "https://finance.yahoo.com/news/minnesota-jury-delivers-65-5-225400354.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "be900566-a5b0-33e6-a841-75fc28e188a9",
      "content": {
        "id": "be900566-a5b0-33e6-a841-75fc28e188a9",
        "contentType": "STORY",
        "title": "Minnesota Jury Delivers $65.5 Million History-Making Verdict Against Johnson & Johnson",
        "description": "",
        "summary": "ST. PAUL, Minn., December 20, 2025--A Minnesota jury awarded $65.5 million to a 37-year-old mother of three minor children after finding in her favor in a lawsuit against Johnson & Johnson, concluding that the company’s talc products exposed her to asbestos and contributed to her developing peritoneal mesothelioma, a cancer of the peritoneal lining in the stomach.",
        "pubDate": "2025-12-20T00:11:00Z",
        "displayTime": "2025-12-20T00:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a9d42a15e9ca5fbef5a484db81a23082",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZgU89C0BFGGRLLjLOhyx4Q--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a9d42a15e9ca5fbef5a484db81a23082.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gmucHAyM79GktibYEAJjyw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a9d42a15e9ca5fbef5a484db81a23082.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/minnesota-jury-delivers-65-5-225400354.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/minnesota-jury-delivers-65-5-225400354.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-20T10:06:49+00:00",
    "headline": "What Developments Are Shifting the Narrative for Johnson & Johnson?",
    "summary": "Johnson & Johnson’s narrative in the market is shifting as its fair value estimate edges up from $202.54 to $209.29 and revenue growth expectations tick higher from 5.23% to about 5.32%, reflecting growing confidence in the company’s long term trajectory. Behind these moves is a more constructive Wall Street view on J&J’s portfolio, from the planned orthopedics separation to resilient demand in Innovative Medicine and MedTech, alongside easing concern around talc litigation and a belief that...",
    "url": "https://finance.yahoo.com/news/developments-shifting-narrative-johnson-johnson-100649159.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "fb8e2910-d904-339f-87d7-69f05da975c6",
      "content": {
        "id": "fb8e2910-d904-339f-87d7-69f05da975c6",
        "contentType": "STORY",
        "title": "What Developments Are Shifting the Narrative for Johnson & Johnson?",
        "description": "",
        "summary": "Johnson & Johnson’s narrative in the market is shifting as its fair value estimate edges up from $202.54 to $209.29 and revenue growth expectations tick higher from 5.23% to about 5.32%, reflecting growing confidence in the company’s long term trajectory. Behind these moves is a more constructive Wall Street view on J&J’s portfolio, from the planned orthopedics separation to resilient demand in Innovative Medicine and MedTech, alongside easing concern around talc litigation and a belief that...",
        "pubDate": "2025-12-20T10:06:49Z",
        "displayTime": "2025-12-20T10:06:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/developments-shifting-narrative-johnson-johnson-100649159.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/developments-shifting-narrative-johnson-johnson-100649159.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]